In this issue:
Pembrolizumab for advanced melanoma
Myeloablative autologous stem-cell transplantation for severe scleroderma
Adjuvant dabrafenib + trametinib in stage III
BRAF-mutated melanoma
Survival outcomes of the CheckMate 067 trial
Keratinocyte cancer incidence in Australia
NMSC incidence in Auckland
Use of systemic agents for paediatric psoriasis
Probiotics in children with atopic dermatitis
Use of fluorouracil cream to prevent NMSC
Hydrochlorothiazide increases risk of NMSC
Please login below to download this issue (PDF)